Article info
PDFPostScript
Letter
Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
- Correspondence to Professor Thomas Meyer, Department of Neurology, Center for ALS and other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, 10117 Berlin, Germany; thomas.meyer{at}charite.de
Citation
Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
Publication history
- Received February 2, 2020
- Revised March 25, 2020
- Accepted April 1, 2020
- First published April 21, 2020.
Online issue publication
August 30, 2020
Article Versions
- Previous version (18 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.